1. Home
  2. TSHA vs HNRG Comparison

TSHA vs HNRG Comparison

Compare TSHA & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • HNRG
  • Stock Information
  • Founded
  • TSHA 2019
  • HNRG 1949
  • Country
  • TSHA United States
  • HNRG United States
  • Employees
  • TSHA N/A
  • HNRG N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • HNRG Coal Mining
  • Sector
  • TSHA Health Care
  • HNRG Energy
  • Exchange
  • TSHA Nasdaq
  • HNRG Nasdaq
  • Market Cap
  • TSHA 403.7M
  • HNRG 432.4M
  • IPO Year
  • TSHA 2020
  • HNRG N/A
  • Fundamental
  • Price
  • TSHA $2.06
  • HNRG $12.85
  • Analyst Decision
  • TSHA Strong Buy
  • HNRG Strong Buy
  • Analyst Count
  • TSHA 8
  • HNRG 1
  • Target Price
  • TSHA $6.63
  • HNRG $13.00
  • AVG Volume (30 Days)
  • TSHA 6.0M
  • HNRG 730.5K
  • Earning Date
  • TSHA 11-13-2024
  • HNRG 11-12-2024
  • Dividend Yield
  • TSHA N/A
  • HNRG N/A
  • EPS Growth
  • TSHA N/A
  • HNRG N/A
  • EPS
  • TSHA N/A
  • HNRG N/A
  • Revenue
  • TSHA $9,915,000.00
  • HNRG $429,359,000.00
  • Revenue This Year
  • TSHA N/A
  • HNRG N/A
  • Revenue Next Year
  • TSHA N/A
  • HNRG $20.84
  • P/E Ratio
  • TSHA N/A
  • HNRG N/A
  • Revenue Growth
  • TSHA N/A
  • HNRG N/A
  • 52 Week Low
  • TSHA $1.19
  • HNRG $4.33
  • 52 Week High
  • TSHA $4.32
  • HNRG $13.57
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 55.32
  • HNRG 67.50
  • Support Level
  • TSHA $1.19
  • HNRG $9.89
  • Resistance Level
  • TSHA $2.63
  • HNRG $13.56
  • Average True Range (ATR)
  • TSHA 0.24
  • HNRG 0.89
  • MACD
  • TSHA 0.08
  • HNRG 0.29
  • Stochastic Oscillator
  • TSHA 60.42
  • HNRG 86.92

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About HNRG Hallador Energy Company

Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.

Share on Social Networks: